Comments

NovoCure Stock Price, Quotes and Forecasts

Q: What sector and industry does NovoCure (NVCR) operate in?

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NVCRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$19.78

0.000.00%

Pre-Market: 4:00 PM EDT

NovoCure (NVCR) Forecast

News Earnings NovoCure (NVCR) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

NovoCure Stock Price, Quotes and Forecasts | NASDAQ:NVCR | Benzinga

Explore NovoCure stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NVCR.

Open	-
Close	-
Volume / Avg.	4.00 / 920.33K
Day Range	- - -
52 Wk Range	11.70 - 34.13
Market Cap	$2.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	5.65%
Days to Cover	4.3

Recent News

NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025

NovoCure's Q4 revenue rose 21% to $161.27M, surpassing expectations, while its loss widened. Annual sales hit $605M, fueled by Optune Gio's expansion.

Vandana Singh

Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Keysight Technologies calling it a "Terrific business."

Avi Kapoor

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, STVN.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	4.00 / 920.33K
Day Range	- - -
52 Wk Range	11.70 - 34.13
Market Cap	$2.17B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	5.65%
Days to Cover	4.3

About NovoCure Ltd

Sector

Health Care

Industry

Health Care Equipment & Supplies

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its bus...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NovoCure (NVCR) stock?

You can purchase shares of NovoCure (NASDAQ:NVCR) through any online brokerage.

View our list of the best stock brokerages

Who are NovoCure (NVCR) competitors?

Other companies in NovoCure’s space includes: Axogen (NASDAQ:AXGN), CeriBell (NASDAQ:CBLL), Kestra Medical Techs (NASDAQ:KMTS), Masimo (NASDAQ:MASI) and Envista Holdings (NYSE:NVST).

What is the forecast, or price target, for NovoCure (NVCR) stock?

NovoCure has a consensus price target of $50.44.

What is the current price for NovoCure (NVCR)?

The stock price for NovoCure (NASDAQ: NVCR) is $19.78 last updated March 24, 2025 at 4:00 PM EDT.

Does NovoCure (NVCR) pay a dividend?

There are no upcoming dividends for NovoCure.

When is NovoCure (NASDAQ:NVCR) reporting earnings?

NovoCure’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is NovoCure (NVCR) going to split?

There is no upcoming split for NovoCure.

What sector and industry does NovoCure (NVCR) operate in?

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.